MARKET

PSTX

PSTX

POSEIDA THERAPEUTICS, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.0000
0.00%
Closed 09:30 09/19 EDT
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PSTX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Industry

Biotechnology & Medical Research
+0.06%
Pharmaceuticals & Medical Research
+0.42%

Hot Stocks

Name
Price
%Change

About PSTX

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops gene engineering technologies to create therapeutics for patients with unmet medical need. The Company has built a pipeline of autologous and allogeneic chimeric antigen receptor thymus (T) cell product candidates, which is focused on the treatment of hematological malignancies and solid tumors. Its P- bone marrow cell maturation antigen (BCMA)-101 is an autologous chimeric antigen receptor (CAR)-T therapy being developed to treat patients with relapsed or refractory multiple myeloma. P-PSMA-101 is an autologous CAR-T product candidate that enables treatment of patients with castrate-resistant prostate cancer (CRPC). P-BCMA-ALLO1 is an allogeneic CAR-T product candidate using cells derived from a donor as starting material that enables treatment of patients with multiple myeloma from a single manufacturing run.
More

Webull offers Poseida Therapeutics Inc (PSTX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.